A molecular basis of activation of the alternative pathway of human complement
- PMID: 390986
A molecular basis of activation of the alternative pathway of human complement
Abstract
The fluid phase interaction of native C3, B, D and P continuously generates C3b; C3b complexes with B to permit cleavage-activation by D, thereby generating C3b, Bb, the amplification C3 convertase. C3b, Bb formed in the fluid phase or on a non-activating surface for the alternative pathway undergoes decay-dissociation through release of Bi, and the residual C3b undergoes cleavage inactivation by the C3b inactivator (C3bINA). The capacity of P to stabilize C3b, Bb and therby augment C3 cleavage is counterbalanced by beta 1H, which inactivates the convertase by displacing Bi and facilitates the inactivation of residual C3b by C3bINA. Transition to amplified C3 cleavage is achieved because the surface characteristics of an activating particle protect C3b from inactivation by C3bINA in the presence of beta 1H, and the stabilized alternative pathway convertase, P, C3b, Bb, from extrinsic decay-dissociation by beta 1H. Natural activating surfaces such as zymosan (Zy) and rabbit erythrocytes are relatively deficient in sialic acid residues as compared to non-activating surfaces such as sheep erythrocytes (Es). Sialic acid residues on C3b-bearing particles augment binding of beta 1H to favor competition with B, inactivation of C3b and decay-dissociation of C3b, Bb. The absence of this carbohydrate on the membrane in the environment of C3b results in low affinity binding of beta 1H, a circumstance that permits uptake of B to form the amplification convertase and impairs extrinsic decay of the C3-cleaving enzyme. This natural humoral host resistance reaction based on the relative content of sialic acid on target particles has a cellular counterpart in the capacity of human monocytes to engage in antibody-independent phagocytosis of sialic acid-deficient cells. Thus, the non-immune host may respond to such cells by dual humoral and cellular recognition mechanisms and this response may represent a primordial basis for protection against microbial invasion.
Similar articles
-
Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.J Exp Med. 1977 Jul 1;146(1):22-33. doi: 10.1084/jem.146.1.22. J Exp Med. 1977. PMID: 559720 Free PMC article.
-
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.Transplant Proc. 1977 Mar;9(1):729-39. Transplant Proc. 1977. PMID: 325806 Review.
-
Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.Proc Natl Acad Sci U S A. 1977 Apr;74(4):1683-7. doi: 10.1073/pnas.74.4.1683. Proc Natl Acad Sci U S A. 1977. PMID: 266208 Free PMC article.
-
Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.J Exp Med. 1979 Nov 1;150(5):1202-15. doi: 10.1084/jem.150.5.1202. J Exp Med. 1979. PMID: 501288 Free PMC article.
-
The natural modulation of the amplification phase of complement activation.Transplant Rev. 1976;32:12-25. doi: 10.1111/j.1600-065x.1976.tb00226.x. Transplant Rev. 1976. PMID: 62426 Review.
Cited by
-
Exceptional matters.Lancet. 2004 Dec 11-17;364(9451):2142-51. doi: 10.1016/S0140-6736(04)17556-9. Lancet. 2004. PMID: 15589313 Free PMC article. No abstract available.
-
Electron microscopy of the first component of human complement.Surv Immunol Res. 1982;1(4):305-15. doi: 10.1007/BF02918541. Surv Immunol Res. 1982. PMID: 6314471 Review. No abstract available.
-
Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.PLoS One. 2017 Mar 8;12(3):e0172675. doi: 10.1371/journal.pone.0172675. eCollection 2017. PLoS One. 2017. PMID: 28273167 Free PMC article.
-
Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.mBio. 2013 Oct 15;4(5):e00339-13. doi: 10.1128/mBio.00339-13. mBio. 2013. PMID: 24129254 Free PMC article.
-
Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.J Biol Chem. 2011 Mar 11;286(10):8297-8307. doi: 10.1074/jbc.M110.184838. Epub 2011 Jan 18. J Biol Chem. 2011. PMID: 21245150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous